← Back to Search

Oral Rehydration Solution

Oral Rehydration Solution for Hydration

N/A
Recruiting
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 weeks
Awards & highlights

Study Summary

This trial will study how well an oral rehydration solution works to help adult athletes stay hydrated during exercise.

Who is the study for?
Healthy adult athletes aged 18-30, with specific cardiovascular fitness levels (VO2max criteria), stable weight and blood pressure. Women must be non-pregnant, at least 6 months postpartum, and have regular menstrual cycles. Participants can't have serious recent injuries, certain diseases like diabetes or heart conditions, or be using substances that affect hydration.Check my eligibility
What is being tested?
The study is testing the effectiveness of an oral rehydration solution (ORS) compared to water and no intervention in hydrating athletes during exercise. It's a controlled experiment where participants are randomly assigned to one of the groups and switch between treatments.See study design
What are the potential side effects?
Since ORS is generally considered safe for most people, side effects are minimal but may include mild digestive discomfort or an allergic reaction if sensitive to ingredients in the ORS.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anaerobic Power
Secondary outcome measures
Body Mass
Leg Strength
Muscular Force
+2 more
Other outcome measures
Adverse Events
Blood Biomarkers Creatinine
Blood Biomarkers Cytokines
+14 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: WaterExperimental Treatment1 Intervention
Water with flavor
Group II: Oral Rehydration SolutionExperimental Treatment1 Intervention
ORS with carbohydrate
Group III: Control GroupExperimental Treatment1 Intervention
No intervention

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
167 Previous Clinical Trials
33,460 Total Patients Enrolled
Jennifer Williams, MPHStudy ChairAbbott Nutrition
6 Previous Clinical Trials
893 Total Patients Enrolled

Media Library

Oral Rehydration Solution 1 (Oral Rehydration Solution) Clinical Trial Eligibility Overview. Trial Name: NCT05569044 — N/A
Hydration Research Study Groups: Oral Rehydration Solution, Control Group, Water
Hydration Clinical Trial 2023: Oral Rehydration Solution 1 Highlights & Side Effects. Trial Name: NCT05569044 — N/A
Oral Rehydration Solution 1 (Oral Rehydration Solution) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05569044 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for participation in this research restricted to individuals younger than forty?

"This medical trial is available to individuals aged 18-30."

Answered by AI

Are there any openings in this research initiative for participants?

"At present, the clinical trial listed on clinicaltrials.gov is not in need of recruits. Initially posted October 1st 2022 and last updated October 3rd 2022, there are currently two other studies actively recruiting patients for participation."

Answered by AI

For whom is this medical experiment suitable?

"This clinical trial is currently recruiting 24 participants between the ages of 18 and 30 who are deemed to be adequately hydrated. Prospective enrollees must meet a range of criteria, including having their body fat percentage below 15% for males or 20% for females; an appropriately elevated cycling VO2max; regular menstrual cycles (if female); being willing to consume grape-flavored beverages during the study period; stable weight over two months prior to screening visit etc. In addition, all applicants will need to sign an IRB-approved informed consent form as well as provide HIPAA authorization before any participation in this research project can commence."

Answered by AI
~10 spots leftby Apr 2025